ScPharmaceuticals, Inc. (SCPH) Reports Q3 Loss, Lags Revenue Estimates
Portfolio Pulse from
ScPharmaceuticals, Inc. (SCPH) reported a Q3 loss of $0.37 per share, missing the Zacks Consensus Estimate of a $0.30 loss. This is an improvement from the $0.41 loss per share a year ago.
November 13, 2024 | 11:30 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
ScPharmaceuticals reported a Q3 loss of $0.37 per share, missing the expected loss of $0.30. This is an improvement from last year's $0.41 loss.
The reported loss per share of $0.37 was worse than the expected $0.30, which is likely to negatively impact the stock price in the short term. However, the loss is an improvement from the previous year's $0.41, which may mitigate some negative sentiment.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100